Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleOsimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.AuthorsNakashima, Kazuhisa; Ozawa, Yuichi; Daga, Haruko; Imai, Hisao; Tamiya, Motohiro; Tokito, Takaaki; Kawamura, Takahisa; Akamatsu, Hiroaki; Tsuboguchi, Yuko; Takahashi, Toshiaki; Yamamoto, Nobuyuki; Mori, Keita; Murakami, HaruyasuPublicationInvestigational New Drugs, 2020, Vol 38, Issue 6, p1854ISSN0167-6997Publication typeArticleDOI10.1007/s10637-020-00943-0